Column: The Ozempic revolution in weight-loss drugs exposes the weakest links in our healthcare system — drug pricing and insurance
7 months ago

Column: The Ozempic revolution in weight-loss drugs exposes the weakest links in our healthcare system — drug pricing and insurance

LA Times  

The diabetes and weight-loss drug Ozempic. This limits the length of time that health gains can be internalized as reduced claims.’ — David Anderson, University of South Carolina health policy expert Yet millions of Americans are unable to access these drugs, thanks to the two big, interrelated flaws in our healthcare system: unrestrained pricing by drug companies and the economics of health insurance. Some experts estimate that expanding coverage of the weight-loss drugs would cost Medicare up to $6.1 billion a year, assuming that 10% of patients eligible for the coverage actually receive prescriptions. Unless the U.S. moves toward a single-payer healthcare system and starts to place limits on drug prices, it’s the manufacturers of the weight-loss drugs that will reap most of the benefits. To put it another way, America’s 20th century healthcare system is coming face to face with a spate of 21st century drugs.

Health Healthcare Weight Loss Medicare Drugs Coverage Weight Ozempic System Wegovy Bmi Drug Pricing Wegovy And Ozempic Our Healthcare System Obese  links  ozempic  exposes  drugs  weight  coverage  weakest  obese  medicare  revolution  system  health  drug  pricing  healthcare  weightloss  insurance

History of this topic

Behind America's decades-long fight to dismantle the PBS
6 days, 23 hours ago

Behind America's decades-long fight to dismantle the PBS

ABC  

For decades, America's pharmaceutical giants have been plotting to torpedo Australia's Pharmaceuticals Benefits Scheme. Twenty years ago, they scored a huge victory when they secured major concessions from the Howard government, as America and Australia negotiated the Australia-US Free Trade Agreement. With Trump again in the White House, this time threatening a global trade war, America's pharmaceutical industry lobbyists, having …

Why don't celebrities admit to taking weight-loss medicine? Expert answers at India Today Conclave
2 weeks, 6 days ago

Why don't celebrities admit to taking weight-loss medicine? Expert answers at India Today Conclave

India Today  

Many celebrities who have undergone dramatic transformations have avoided admitting to using weight loss drugs, despite its growing popularity. Addressing this reluctance, Vikrant Shrotriya, Corporate Vice President & Managing Director of Novo Nordisk India, said, "They just want to pat their back that they have fantastic genes. Watch the full India Today Conclave 2025 here During a session on obesity …

Medicare spending on diabetes drugs surged over 5 years, US report shows
1 month ago

Medicare spending on diabetes drugs surged over 5 years, US report shows

Live Mint  

Feb 26 - Medicare spending on some diabetes drugs, including popular treatments such as Ozempic, surged nearly five-fold to $35.8 billion between 2019 and 2023, a U.S. government watchdog's report showed this week. But that of popular GLP-1 drugs such as Novo Nordisk's Ozempic surged over the five years, the report by the U.S. Department of Health and Human Services' …

Supplies of high-demand obesity drugs are improving – but they’re not easier to get
1 month ago

Supplies of high-demand obesity drugs are improving – but they’re not easier to get

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Patients struggle with lack of consistent coverage for popular weight-loss drugs
1 month ago

Patients struggle with lack of consistent coverage for popular weight-loss drugs

Associated Press  

Supplies of high-demand obesity treatments are improving, but that doesn’t mean it’s easier to get them. Many employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t cover the drugs for obesity. The lack of Medicare coverage remains a concern as well, especially for people who retire and move to the government-funded …

Ozempic being ‘sold by drug dealers alongside Class As’
1 month ago

Ozempic being ‘sold by drug dealers alongside Class As’

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Drug dealers are selling weight-loss …

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says
1 month ago

Yearslong shortage of popular weight-loss and diabetes drugs is resolved, FDA says

Associated Press  

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the popular diabetes and obesity treatments continue to improve, federal regulators said Friday. Compounding pharmacies and other entities that have been allowed to make and distribute off-brand copies of the drugs during the shortage will have to wind down …

About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds
1 month, 3 weeks ago

About half of Americans approve of using weight-loss drugs to treat obesity, AP-NORC poll finds

Associated Press  

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health condition tied to weight, but they are not broadly supportive of teens who have obesity using the medications, according to a new poll from The …

More people are paying for weight loss drugs themselves
1 month, 3 weeks ago

More people are paying for weight loss drugs themselves

Dutch News  

The use of weight loss drugs like Ozempic and Wegovy is growing in the Netherlands as more people opt to pay for prescriptions themselves, according to research by current affairs show Nieuwsuur. Last summer, the Dutch health council advised health minister Fleur Agema against including these drugs in the basic health insurance package, citing concerns about long-term health effects and …

Pricey Ozempic for weight loss is increasing the Dutch health gap, experts fear
1 month, 3 weeks ago

Pricey Ozempic for weight loss is increasing the Dutch health gap, experts fear

NL Times  

The number of Netherlands residents using medicines like Ozempic, Wegovy, and Mounjaro for weight loss is increasing significantly. As health insurers don’t reimburse these expensive medicines for weight loss, users have to pay the thousands of euros they cost per year out of their own pocket. Last summer, the Dutch Healthcare Institute advised Health Minister Fleur Agema not to cover …

Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drugs Ozempic
2 months, 1 week ago

Medicare announces 15 new drugs chosen for price negotiations, including popular weight loss drugs Ozempic

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

"They're not shortcuts": How weight loss drugs became the business of shame
2 months, 2 weeks ago

"They're not shortcuts": How weight loss drugs became the business of shame

Salon  

As New Year's resolutions kick into high gear, weight loss goals top many people's lists. "Diet culture plays a significant role in pushing this, too, making people believe that anyone in a larger body is just not trying hard enough, leading to the scorn and derision we see.” We need your help to stay independent Subscribe today to support Salon's …

UK obesity rates ‘may start dropping significantly’ this year because of weight loss jabs
2 months, 2 weeks ago

UK obesity rates ‘may start dropping significantly’ this year because of weight loss jabs

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Why the Obesity Drug Revolution Is a Work in Progress
2 months, 3 weeks ago

Why the Obesity Drug Revolution Is a Work in Progress

Bloomberg  

A new class of weight-loss drugs known as GLP-1s are proving to be game changers for people with obesity. They’re also minting billions for pharmaceutical companies, especially the companies that developed them, Eli Lilly & Co. and Novo Nordisk A/S. It also remains unclear whether pharma companies can actually deliver on the promise of even better weight-loss drugs — part …

MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses they could treat
2 months, 3 weeks ago

MATT RIDLEY: Move over, Ozempic: Why an astonishing new class of weight-loss drugs will soon end obesity FOR EVER - and here are the other surprising illnesses they could treat

Daily Mail  

Imagine if you could eat your fill on Christmas Day then dial down your appetite for January. The past year has seen the rise of myriad weight-loss drugs that are getting better and achieving results where decades of hectoring and dieting have failed – in yet another miracle of biomedical science. Yes cancer, dementia and anxiety are on the rampage; …

FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated
2 months, 3 weeks ago

FDA declares the shortage of obesity drug Zepbound has ended. The results are complicated

NPR  

FDA declares the shortage of obesity drug Zepbound has ended. SCOTT SIMON, HOST: The drug Zepbound might not have the same name recognition as Ozempic, but it's another in the class to treat obesity and Type 2 diabetes. The compounders said there was no way the shortage could be over, because many patients still couldn't fill their name-brand prescriptions, and …

Competition will make weight-loss drugs better, cheaper and bigger
3 months ago

Competition will make weight-loss drugs better, cheaper and bigger

Live Mint  

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking remedies for erectile dysfunction and hair loss. Patrik Jonsson, head of the division at Eli Lilly that is responsible for weight-loss drugs, says that the level of competition is something he has never experienced before. In China nearly half …

Opinion: Weight-loss drugs are great, but real food still matters
3 months, 1 week ago

Opinion: Weight-loss drugs are great, but real food still matters

LA Times  

Salty and fatty manufactured foods, along with sweet ones, have been engineered to encourage snacking and excessive eating. Companies have reshaped the food system to produce ultraprocessed, hyperpalatable and highly profitable foods, leading people to snack more, eat larger portions and prepare fewer meals themselves. Just as health experts urge us to reduce our intake of salt, fat and sugar, …

US obesity rate declines for the first time in a decade, weight-loss drugs play key role
3 months, 1 week ago

US obesity rate declines for the first time in a decade, weight-loss drugs play key role

Live Mint  

For the first time in a decade, the United States is seeing a slight decline in obesity rates. A new study published in JAMA Health Forum titled "Changes in Adult Obesity Trends in the US" reveals that obesity rates fell from 46% in 2022 to 45.6% in 2023, marking the first recorded drop in this trend in at least a …

Consultations for obesity drug prescriptions are way up over 2023, survey finds
3 months, 2 weeks ago

Consultations for obesity drug prescriptions are way up over 2023, survey finds

NPR  

Consultations for obesity drug prescriptions are way up over 2023, survey finds Appointments with health professionals for obesity drug consultations are way up, according to data from Zocdoc, a provider of scheduling services. SYDNEY LUPKIN, BYLINE: Doctor Sarah Nosal, a family physician in the South Bronx, New York, says a lot more of her patients have come in asking about …

Doctors weigh societal costs of using drugs to treat obesity crisis
3 months, 2 weeks ago

Doctors weigh societal costs of using drugs to treat obesity crisis

ABC  

It could be one of the most transformative medical advancements since the contraceptive pill: an injection of a peptide that mimics a hormone to suppress appetite. Yet beyond the controversies over side effects — nausea, headaches and even pancreatitis — these drugs mark a pivotal moment in addressing one of the world's most pressing health crises. A national report — …

RFK Jr. Could Tank Biden's Ozempic Decision
3 months, 3 weeks ago

RFK Jr. Could Tank Biden's Ozempic Decision

Huff Post  

LOADING ERROR LOADING The prospect of Robert F. Kennedy Jr. presiding over the Department of Health and Human Services has sparked a lot of conversation about vaccines. The country’s national health system still covers and supports use of the new anti-obesity drugs, though guidelines urge providers and patients to try cheaper alternatives first. The group is among those that have …

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision
4 months ago

Cheap Ozempic? Millions of obese Americans wait on Trump’s decision

The Independent  

The latest headlines from our reporters across the US sent straight to your inbox each weekday Your briefing on the latest headlines from across the US Your briefing on the latest headlines from across the US SIGN UP I would like to be emailed about offers, events and updates from The Independent. The rule, unveiled on Tuesday by the Health …

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs
Trending News
4 months ago

Cheap Ozempic? How millions of Americans with obesity may get access to costly weight-loss drugs

Associated Press  

WASHINGTON — Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $ 35 billion proposal from the Biden administration is blessed by President-elect Donald Trump. The rule, unveiled Tuesday by the Health and Human Services Department, would require Medicare and Medicaid to cover weight-loss drugs like Wegovy or Zepbound …

Biden proposes huge expansion of weight loss drug access
4 months ago

Biden proposes huge expansion of weight loss drug access

Raw Story  

by Danny KEMP Outgoing U.S. President Joe Biden proposed Tuesday to give millions more Americans access to weight loss drugs -- but Donald Trump's incoming health chief looked set to shoot down the idea. Any plan to increase US public health insurance spending would also likely run foul of Trump's bid to slash government budgets and waste. Trump said last …

Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans
4 months ago

Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans

Associated Press  

WASHINGTON — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Zepbound covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning. The costly proposal from the U.S. Department of Health and Human Services immediately sets the stage for a showdown between the powerful pharmaceutical industry and Robert …

Biden proposes Medicare, Medicaid cover costly weight-loss drugs for millions of obese Americans
4 months ago

Biden proposes Medicare, Medicaid cover costly weight-loss drugs for millions of obese Americans

New Indian Express  

WASHINGTON: Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed Tuesday morning. The costly proposal from the U.S. Department of Health and Human Services immediately sets the stage for a showdown between the powerful pharmaceutical industry and Robert F …

RFK plans to restrict use of weight-loss drugs like Ozempic
4 months, 1 week ago

RFK plans to restrict use of weight-loss drugs like Ozempic

Daily Mail  

Robert F. Kennedy Junior wants to scale back the nation's reliance on Ozempic, claiming Americans hooked on the drug are 'stupid' and 'addicted.' Estimates suggest more than 9million prescriptions for Ozempic and similar weight loss drugs are written every year in the U.S. — one of the world's fattest nations. Mr Kennedy, a famed vaccine skeptic who claims WiFi causes …

RFK wants to restrict weight-loss drugs like Ozempic... says they will not 'Make America Healthy Again'
4 months, 1 week ago

RFK wants to restrict weight-loss drugs like Ozempic... says they will not 'Make America Healthy Again'

Daily Mail  

Robert F. Kennedy Junior wants to scale back the nation's reliance on Ozempic, claiming Americans hooked on the drug are 'stupid' and 'addicted.' Estimates suggest more than 9million prescriptions for Ozempic and similar weight loss drugs are written every year in the US — one of the world's fattest nations. Authorities in Denmark, home to its manufacturer Novo Nordisk, have …

Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
4 months, 1 week ago

Medicaid fuels US coverage of Novo, Lilly weight-loss drugs

Live Mint  

* U.S. government health plans cover 52.2 million for new weight-loss drugs * An estimated 24.4 million in commercial plans have similar coverage * Fourteen state Medicaid programs cover GLP-1 drugs for obesity By Chad Terhune Nov 18 - U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the reimbursement available …

Doctors say RFK Jr.’s anti-Ozempic stance perpetuates stigma and misrepresents evidence
4 months, 1 week ago

Doctors say RFK Jr.’s anti-Ozempic stance perpetuates stigma and misrepresents evidence

CNN  

Editor’s note: Watch “Dr. “They’re counting on selling it to Americans because we’re so stupid and so addicted to drugs,” Kennedy said in an appearance with Fox News’ Greg Gutfeld that he posted to Instagram last month, concluding that Ozempic, a wildly popular medicine approved to treat type 2 diabetes and used off-label for weight loss, is not going to …

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy
Trending News
4 months, 1 week ago

Wegovy/Mounjaro: The UK thinks weight loss drugs could ease unemployment. Experts say that’s a fantasy

CNN  

London CNN — Weight loss drugs such as Wegovy and Ozempic have been hailed worldwide as revolutionary for medicine. British Prime Minister Keir Starmer has said that his government needs to “think differently” about how to reduce pressure on the country’s national health care system, overburdened amid staffing shortages and funding pressures. Tom Little/Reuters The government trial studying links between …

Ten Americans die and 100 are hospitalized after taking Ozempic-like drugs
4 months, 3 weeks ago

Ten Americans die and 100 are hospitalized after taking Ozempic-like drugs

Daily Mail  

Ten people have died and 100 have been hospitalized after taking pharmacy-made copycat versions of Ozempic, its manufacturer has revealed. Ozempic maker Novo Nordisk claims these off-brand versions of its drugs are made with little regulation or oversight which raises the risk that someone could fall ill after using them. Novo revealed the cases after asking the FDA to ban …

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares
4 months, 3 weeks ago

Obesity Pill Data Portend Competition, Hitting Drugmaker Shares

Live Mint  

-- Obesity pill data released by Viking Therapeutics Inc. and AstraZeneca Plc at a big conference foreshadowed an increasingly competitive landscape for weight-loss therapies, sending down shares of drugmakers in the field. Effectiveness and safety data from Viking’s study, released Sunday at an industry conference, show that an obesity pill could be a reality soon: People who took 100-milligram doses …

Big Pharma’s obesity bonanza faces new tests
4 months, 3 weeks ago

Big Pharma’s obesity bonanza faces new tests

Live Mint  

In terms of recent stock-market frenzies, the Ozempic trade nearly tops the list, second only to speculation that artificial intelligence will soon be writing this column. Powerful weight-loss drugs like Wegovy and Zepbound have driven nearly $1 trillion in market-capitalization gains, with most of those gains flowing to Eli Lilly and Novo Nordisk, the dominant players in the obesity-drug market. …

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage
4 months, 3 weeks ago

Ozempic, Wegovy considered ‘available’ after more than 2 years in shortage

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Live your life healthier and happier with our free weekly Living Well newsletter SIGN UP I would like to be emailed about offers, events and updates from The Independent. …

Influencers are being offered tens of thousands of dollars to hawk weight-loss drugs
4 months, 3 weeks ago

Influencers are being offered tens of thousands of dollars to hawk weight-loss drugs

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Influencers have been offered tens …

Weight-loss drugs on the NHS? That’s just an admission of failure
5 months, 1 week ago

Weight-loss drugs on the NHS? That’s just an admission of failure

The Independent  

Both the prime minister and the health secretary have proposed that weight-loss jabs would help the unemployed return to the workplace. Archbishop Justin Welby has described a parliamentary bill that would give terminally ill people in England and Wales the right to end their lives as “dangerous”. There are many complex discussions to be had around this issue, but do …

Doctors’ warning over Ozempic and Wegovy weight-loss jabs on NHS
5 months, 1 week ago

Doctors’ warning over Ozempic and Wegovy weight-loss jabs on NHS

The Independent  

Sign up to our free Living Well email for advice on living a happier, healthier and longer life Live your life healthier and happier with our free weekly Living Well newsletter Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. The …

Your employer may start covering weight-loss drugs soon
5 months, 2 weeks ago

Your employer may start covering weight-loss drugs soon

CNN  

CNN — Hoping your company will begin paying for anti-obesity medications like Wegovy? While employers typically cover the medications for diabetes, fewer of them do so for weight loss, in part because of the drugs’ high prices — which have also limited Americans’ access to them. Hollie Adams/Reuters Still, more than a quarter of employers are considering adding coverage for …

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?
5 months, 3 weeks ago

The US has passed peak obesity, a new survey suggests. Is it the Ozempic effect?

The Independent  

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ /verifyErrors }} The United …

Cost of weight-loss drugs 'cheaper than doing nothing'
6 months ago

Cost of weight-loss drugs 'cheaper than doing nothing'

China Daily  

Pens for the diabetes drug Ozempic sit on a production line at Danish drugmaker Novo Nordisk's site in Hillerod, Denmark on Sept 26, 2023. New research conducted by ING Bank has found obesity is costing the United Kingdom 100 billion pounds a year in lost productivity and healthcare expenses, The Guardian newspaper reported. ING healthcare analyst Diederik Stadig told the …

Cost of weight-loss drugs 'cheaper than doing nothing'
6 months ago

Cost of weight-loss drugs 'cheaper than doing nothing'

China Daily  

Pens for the diabetes drug Ozempic sit on a production line at Danish drugmaker Novo Nordisk's site in Hillerod, Denmark on Sept 26, 2023. New research conducted by ING Bank has found obesity is costing the United Kingdom 100 billion pounds a year in lost productivity and healthcare expenses, The Guardian newspaper reported. ING healthcare analyst Diederik Stadig told the …

1 in 4 People Taking Weight Loss Meds & Injections on Their Own, Survey Flags Fatal Risks
6 months, 1 week ago

1 in 4 People Taking Weight Loss Meds & Injections on Their Own, Survey Flags Fatal Risks

News 18  

Crores of people around the world are struggling with obesity and many are obsessed with losing weight. A recent study reveals that one out of four people are using weight loss injections and medicines without consulting any doctor. They are avoiding visiting doctors and are using unlicensed online pharmacies for weight loss drugs which can endanger their lives. Shengyi Mao, …

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions
6 months, 3 weeks ago

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions

NPR  

Drugmakers say obesity medicine shortages are easing, but patients struggle to fill prescriptions toggle caption Michael Siluk/Getty Images Bill Coombs, who lives in Boston’s South End, has lost 28 pounds since he started using the obesity drug Wegovy. They recently said that their drugs are “available” again with the exception of the starting dose of Novo Nordisk’s Wegovy. ” Novo …

Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers
8 months, 3 weeks ago

Ozempic maker slams Biden after the president accused the drug company of ‘ripping off’ US consumers

The Independent  

Sign up for the daily Inside Washington email for exclusive US coverage and analysis sent to your inbox Get our free Inside Washington email Get our free Inside Washington email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy The company behind the popular weight loss and diabetes drug …

Why would you risk taking ‘Fauxzempic’?
9 months ago

Why would you risk taking ‘Fauxzempic’?

The Independent  

Over the past two years, there has only been one word worth knowing about weight loss: Ozempic. When used as a slimming tool, the drug has become so in demand as to trigger global shortages; it’s made its manufacturers, Novo Nordisk, Europe’s most valuable company, and has gone from Hollywood’s “dirty little secret” to a status symbol among those no …

In China, weight-loss drugs are becoming big business
9 months, 3 weeks ago

In China, weight-loss drugs are becoming big business

Al Jazeera  

Chinese pharmaceutical companies are racing to roll out weight-loss drugs amid the popularity of Ozempic. Ozempic was approved in China to treat diabetes in 2021, but it has been its anti-obesity ingredient, semaglutide, that has fuelled demand for what many Chinese refer to as the “internet celebrity weight-loss drug”. “Weight-loss drugs fall within a market with massive growth potential in …

Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?
9 months, 3 weeks ago

Millions of Americans need drugs like Ozempic. Will it bankrupt the healthcare system?

LA Times  

Injectable weight-loss drugs can prevent serious health problems, which makes them extremely valuable. The financial impact on Medicare is tempered by a 2003 federal law that prevents the government health insurance program from covering weight-loss medications.The drugs can be added to formularies if prescribed for another “medically accepted indication,” such as to treat type 2 diabetes or reduce heart risk, …

Discover Related